Chromotek GmbH

Chromotek GmbH, a biotech spin-off from the LMu Munich founded in 2008, aims to establish Chromobodies®, (which are highly efficient functional binding reagents for a multitude of immuno-logical and biochemical applications), as superior substitutes for conventional antibodies in areas like proteome analysis, target screening/validation, cell sorting and live cell HCA. on the basis of its technology (patent pending).

The team of 5 biologists around CEO Ulrich Rothbauer develops novel analytical and preparative solutions for the biomolecular research market. It has successfully launched the GFP-trap®, the best commercially available pull-down reagent for GFP and/or GFP fusion proteins.
Type: NORMAL
Address: Großhadernerstr. 2, D-82152 Martinsried
Website: www.chromotek.com
Phone: +49 (0) 89 23526927
Email: u.rothbauer@chromotek.com
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.